We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+113.09%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$452M
AUM Growth
+$130M
(+40%)
Cap. Flow
-$18.5M
Cap. Flow
% of AUM
-4.08%
Top 10 Holdings %
Top 10 Hldgs %
10.66%
Holding
352
New
147
Increased
15
Reduced
84
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
+$3.03M |
| 2 |
OneSpan
OSPN
|
+$2.96M |
| 3 |
Anterix
ATEX
|
+$2.79M |
| 4 |
Calix
CALX
|
+$2.73M |
| 5 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
+$2.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axsome Therapeutics
AXSM
|
+$3.54M |
| 2 |
Karyopharm Therapeutics
KPTI
|
+$3.44M |
| 3 |
Teladoc Health
TDOC
|
+$3.2M |
| 4 |
Krystal Biotech
KRYS
|
+$3M |
| 5 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
+$2.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.95% |
| 2 | Technology | 21.89% |
| 3 | Consumer Discretionary | 16.2% |
| 4 | Industrials | 10.05% |
| 5 | Consumer Staples | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
AudioEye
AEYE
$74.2M
| $917K | 0.2% |
+91,718
| New | +$699K |
|
|
MODN
202
DELISTED
MODEL N, INC.
MODN
| $905K | 0.2% |
26,041
-58,839
| -69% | -$1.71M |
|
203
Celldex Therapeutics
CLDX
$3.22B
| $899K | 0.2% |
+69,126
| New | +$306K |
|
204
Climb Global Solutions
CLMB
$506M
| $896K | 0.2% |
+139,444
| New | +$662K |
|
205
Vitamin Cottage Natural Grocers
NGVC
$736M
| $855K | 0.19% |
+57,439
| New | +$699K |
|
|
AKTS
206
DELISTED
Akoustis Technologies Inc
AKTS
| $841K | 0.19% |
+101,397
| New | +$784K |
|
|
PRNB
207
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $841K | 0.19% |
14,067
-47,764
| -77% | -$2.95M |
|
|
FUV
208
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $840K | 0.19% |
+7,891
| New | +$393K |
|
209
Kodiak Sciences
KOD
$2.73B
| $839K | 0.19% |
15,504
-23,078
| -60% | -$1.3M |
|
210
PJT Partners
PJT
$4.45B
| $837K | 0.19% |
+16,312
| New | +$804K |
|
211
Pro-Dex
PDEX
$212M
| $835K | 0.18% |
46,848
| – | – |
|
|
SAFE
212
DELISTED
Safehold Inc.
SAFE
| $828K | 0.18% |
14,397
-15,228
| -51% | -$834K |
|
213
DLH Holdings
DLHC
$70.1M
| $809K | 0.18% |
+110,241
| New | +$689K |
|
214
Apyx Medical
APYX
$174M
| $800K | 0.18% |
+144,224
| New | +$599K |
|
|
PFSW
215
DELISTED
PFSweb, Inc.
PFSW
| $798K | 0.18% |
+119,449
| New | +$633K |
|
216
GeoPark
GPRK
$616M
| $795K | 0.18% |
+81,201
| New | +$729K |
|
217
AudioCodes
AUDC
$251M
| $781K | 0.17% |
+24,562
| New | +$755K |
|
218
Axcelis
ACLS
$4.2B
| $774K | 0.17% |
27,803
| – | – |
|
|
DLA
219
DELISTED
Delta Apparel Inc.
DLA
| $773K | 0.17% |
+63,815
| New | +$729K |
|
|
RVNC
220
DELISTED
Revance Therapeutics, Inc.
RVNC
| $770K | 0.17% |
31,552
-53,750
| -63% | -$1.06M |
|
|
PRVB
221
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $762K | 0.17% |
54,020
-56,524
| -51% | -$714K |
|
|
NBSE
222
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $756K | 0.17% |
4,304
-897
| -17% | -$150K |
|
223
Beam Global
BEEM
$24.9M
| $752K | 0.17% |
75,382
-25,044
| -25% | -$195K |
|
224
Educational Development Corp
EDUC
$11.8M
| $737K | 0.16% |
+76,624
| New | +$482K |
|
225
Chefs' Warehouse
CHEF
$4.43B
| $733K | 0.16% |
+53,960
| New | +$745K |
|
Similar funds
RWM
MCM
HP
OMG
ICCFIA
WFAL
WCM
TSS
EAM Investors's Q2 2020 Portfolio in Review
As of Q2 2020, EAM Investors held 352 positions worth $452M, up 40% from $322M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
EAM Investors withdrew a net $18.5M in Q2 2020, closing 97 positions and reducing 84 holdings. Its most notable exit was Karyopharm Therapeutics, an estimated $3.44M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 40% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in Aspira Women's Health Inc. Common Stock worth $2.61M.
- EAM Investors's largest Q2 2020 buy was Aspira Women's Health Inc. Common Stock: 45,313 shares worth $2.61M.
- EAM Investors added most to Purple Innovation in Q2 2020, an estimated $2.04M increase.
- EAM Investors's biggest Q2 2020 reduction was Axsome Therapeutics, cutting an estimated $3.54M.
- EAM Investors fully exited Karyopharm Therapeutics in Q2 2020, selling an estimated $3.44M.
- EAM Investors's ten largest holdings make up 11% of its $452M portfolio in Q2 2020.
- EAM Investors opened 147 new positions and closed 97 in Q2 2020.
- EAM Investors's portfolio value rose 40% quarter-over-quarter to $452M.
Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.